Acute Myeloid Leukemia in the Elderly: Assessment of Multidrug Resistance (MDR1) and Cytogenetics Distinguishes Biologic Subgroups With Remarkably Distinct Responses to Standard Chemotherapy. A Southwest Oncology Group StudyCatherine P. Leith, Cheryl L. Willman, Kenneth J. Kopecky et al.|Blood|1997Cited by 869
Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study.Catherine P. Leith, Cheryl L. Willman, Kenneth J. Kopecky et al.|PubMed|1999Cited by 579
The long noncoding RNA Chaer defines an epigenetic checkpoint in cardiac hypertrophyYibin Wang, He Wang, Chen Gao et al.|Nature Medicine|2016Cited by 393
Characterization and Use of an Antibody Detecting the CBFβ-SMMHC Fusion Protein in inv(16)/t(16;16)-Associated Acute Myeloid LeukemiasDavid S. Viswanatha, Cheryl L. Willman, I‐Ming Chen et al.|Blood|1998Cited by 23
Antiretroviral Drug Use in a Cohort of HIV-Uninfected Women in the United States: HIV Prevention Trials Network 064I‐Ming Chen, Susan H. Eshleman, William Clarke et al.|PLoS ONE|2015Cited by 13